University of California San Francisco
Give to UCSF
Organ-transplant recipients often reject donated organs, but a new, two-pronged strategy developed by UCSF researchers to specifically weaken immune responses that target transplanted tissue has shown promise.
Scientists, harnessing the power of regenerative medicine, have developed a technique in animal models that could replenish the cells destroyed by type 1 diabetes.
Two new studies led by UC San Francisco scientists shed new light on the nature of beta cells, the insulin-producing cells in the pancreas that are compromised in diabetes.
A new study by UCSF researchers examines the link between the affordability of healthy food ingredients with certain health outcomes, such as risk for hypoglycemia among people with diabetes.
A new UCSF-led study of nearly 3,000 individuals links obesity to the development of kidney disease.
Taxing sugar-sweetened beverages is likely to decrease consumption, resulting in lower rates of diabetes and heart disease, and these health benefits are expected to be greatest for the low-income, Hispanic and African-American Californians who are at highest risk of diabetes, according to a new analysis led by researchers at UC San Francisco.
Current anti-obesity treatments include strategies to prevent food energy from being absorbed, such as orlistat, which prevents fat absorption from food.
For the worst cases of type 1 diabetes, islet transplantation has freed hundreds of people from complete insulin dependence. UCSF is leading a push to bring this experimental procedure into the mainstream.
Dean Schillinger, MD, a professor of medicine at UC San Francisco, has been awarded the 2013 Everett M. Rogers Public Health Communication Award by the American Public Health Association.
The United States faces a severe shortage of primary health care providers. In a series of papers published in Health Affairs, UCSF researchers advocated a number of potential solutions to the problem.
The Madison Clinic for Pediatric Diabetes at UCSF Benioff Children’s Hospital works with young type 1 diabetes patients to prepare them to manage their own care as they transition to adulthood.
Scientists from UCSF have identified a new way to manipulate the immune system that may keep it from attacking the body’s own molecules in autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis.
An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial, UCSF and Yale University report.
